Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea de Bartolomeis

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
International Review of Neurobiology|March 10, 2004
Postsynaptic density scaffolding proteins at excitatory synapse and disorders of synaptic plasticity: implications for human behavior pathologiesAndrea de Bartolomeis, Germano Fiore
Expert Opinion on Pharmacotherapy|September 6, 2012
Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenanceAndrea de Bartolomeis, Giulio Perugi
Psychopharmacology Bulletin|November 11, 2003
The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapyAndrea de Bartolomeis, Felice Iasevoli
Molecular Neurobiology|July 6, 2012
Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteinsAndrea de Bartolomeis, Carmine Tomasetti
Neurochemical Research|September 20, 2012
Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseasesFelice Iasevoli, Carmine Tomasetti, Andrea de Bartolomeis
CNS Drugs|September 9, 2015
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor AntagonismAndrea de Bartolomeis, Carmine Tomasetti, Felice Iasevoli
Rivista Di Psichiatria|December 21, 2016
[Vortioxetine in the treatment of major depression]Andrea de Bartolomeis, Andrea Fagiolini, Giuseppe Maina
Schizophrenia Research and Treatment|September 19, 2012
Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studiesFabio Panariello, Vincenzo De Luca, Andrea de Bartolomeis
Rivista Di Psichiatria|April 29, 2014
Dandy-Walker syndrome with psychotic symptoms: a case reportElisabetta F Buonaguro, Sara Cimmarosa, Andrea de Bartolomeis
Molecular Neurobiology|September 4, 2013
Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approachesAndrea de Bartolomeis, Gianmarco Latte, Carmine Tomasetti, et al.
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
International Review of Neurobiology|March 10, 2004
Postsynaptic density scaffolding proteins at excitatory synapse and disorders of synaptic plasticity: implications for human behavior pathologiesAndrea de Bartolomeis, Germano Fiore
Expert Opinion on Pharmacotherapy|September 6, 2012
Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenanceAndrea de Bartolomeis, Giulio Perugi
Psychopharmacology Bulletin|November 11, 2003
The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapyAndrea de Bartolomeis, Felice Iasevoli
Molecular Neurobiology|July 6, 2012
Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteinsAndrea de Bartolomeis, Carmine Tomasetti
Neurochemical Research|September 20, 2012
Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseasesFelice Iasevoli, Carmine Tomasetti, Andrea de Bartolomeis
CNS Drugs|September 9, 2015
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor AntagonismAndrea de Bartolomeis, Carmine Tomasetti, Felice Iasevoli
Rivista Di Psichiatria|December 21, 2016
[Vortioxetine in the treatment of major depression]Andrea de Bartolomeis, Andrea Fagiolini, Giuseppe Maina
Schizophrenia Research and Treatment|September 19, 2012
Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studiesFabio Panariello, Vincenzo De Luca, Andrea de Bartolomeis
Rivista Di Psichiatria|April 29, 2014
Dandy-Walker syndrome with psychotic symptoms: a case reportElisabetta F Buonaguro, Sara Cimmarosa, Andrea de Bartolomeis
Molecular Neurobiology|September 4, 2013
Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approachesAndrea de Bartolomeis, Gianmarco Latte, Carmine Tomasetti, et al.
Pageof 20